Dr. Anjali Rohatgi, M.D., Ph.D.

Claim this profile

Washington University School of Medicine

Studies Lung Cancer
1 reported clinical trial
2 drugs studied

Area of expertise

1

Lung Cancer

Anjali Rohatgi, M.D., Ph.D. has run 1 trial for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
EGFR positive

Affiliated Hospitals

Image of trial facility.

Washington University School Of Medicine

More about Anjali Rohatgi, M.D., Ph.D.

Clinical Trial Related

4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials

Treatments Anjali Rohatgi, M.D., Ph.D. has experience with

  • APL-101
  • Osimertinib

Breakdown of trials Anjali Rohatgi, M.D., Ph.D. has run

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Anjali Rohatgi, M.D., Ph.D. specialize in?

Is Anjali Rohatgi, M.D., Ph.D. currently recruiting for clinical trials?

Are there any treatments that Anjali Rohatgi, M.D., Ph.D. has studied deeply?

What is the best way to schedule an appointment with Anjali Rohatgi, M.D., Ph.D.?

What is the office address of Anjali Rohatgi, M.D., Ph.D.?

Is there any support for travel costs?